-
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2024-513889-19-00
5
Multiple Myeloma
-
2024-514243-29-01
5
This is a prospective, French, multicenter, open-label, design, strati
-
2024-514633-38-00
5
Crohn’s Disease
-
2024-515306-61-00
6
Adults diagnosed with lower limbs erysipelas
-
2024-515663-59-00
5
intracerebral haemorrhage
-
2024-516328-32-00
4
CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML)
-
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
-
2024-516796-33-00
4
The medical condition studied in IMMUNO-BOS is Bronchiolitis obliteran
-
2024-517030-17-00
4
Newly diagnosed or relapsing Giant-cell arteritis
-
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
-
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
-
2025-520842-31-00
5
Population of study participants Pregnant women with PPROM at 22 to 33
-
2025-520995-24-00
5
Adult patients treated for haematological disorders, in whom chemother
-
2025-521113-13-00
10
Early Parkinson’s Disease
-
2025-521571-30-00
5
Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (
-
2025-522005-38-00
5
sickle cell anaemia with vaso-occlusive crisis
-
2025-523094-42-00
5
Hirschsprung's disease
-
2025-523264-21-00
10
Semantic Variant Primary Progressive Aphasia
-
2025-523750-14-00
5
refractory hypotension in distributive shock
-
2025-524297-42-00
5
CLTI defined as Rutherford category 4 or 5
-
2025-524697-42-00
5
Pleural infections
-
2024-516527-13-00
11
2026-05-27
Kidney transplantation
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-